|
Volumn 369, Issue 14, 2013, Pages 1376-
|
Clopidogrel with aspirin in minor stroke or transient ischemic attack
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CLOPIDOGREL;
CYTOCHROME P450 2C19;
PURINERGIC P2Y12 RECEPTOR;
ANTITHROMBOCYTIC AGENT;
DRUG DERIVATIVE;
TICLOPIDINE;
ASIAN;
CAUCASIAN;
CEREBROVASCULAR ACCIDENT;
CORONARY ARTERY DISEASE;
CORONARY STENT;
CYP2C19 GENE;
DISEASE ACTIVITY;
DRUG EFFICACY;
DRUG SAFETY;
GENE;
GENE FREQUENCY;
HIGH RISK PATIENT;
HUMAN;
HYPERCOAGULABILITY;
LETTER;
LOSS OF FUNCTION MUTATION;
NEUROPROTECTION;
PRIORITY JOURNAL;
RACE DIFFERENCE;
RISK ASSESSMENT;
RISK REDUCTION;
THROMBOCYTE ACTIVATION;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOSIS;
THROMBOSIS PREVENTION;
TRANSIENT ISCHEMIC ATTACK;
FEMALE;
MALE;
NOTE;
FEMALE;
HUMANS;
ISCHEMIC ATTACK, TRANSIENT;
MALE;
PLATELET AGGREGATION INHIBITORS;
STROKE;
TICLOPIDINE;
|
EID: 84884965360
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1309713 Document Type: Letter |
Times cited : (5)
|
References (4)
|